Harlan Waksal

Professional Background

Harlan Waksal is a distinguished leader in the biotechnology and pharmaceutical sectors, currently serving as the President and CEO of Kadmon Holdings, Inc. With a robust career spanning decades, he has been instrumental in steering innovative enterprises in the medical and biopharmaceutical fields, focusing on the development and commercialization of novel therapies.

Waksal is notably recognized for his pivotal role at ImClone Systems, where he was a co-founder, as well as President, EVPOperations, and a member of the Board of Directors. Under his leadership, ImClone Systems became a key player in the biotechnology industry prior to its acquisition by Eli Lilly and Company. His expertise in business and scientific affairs has greatly benefited companies seeking to navigate the complexities of drug development and market entry.

In addition to his leadership positions at Kadmon and ImClone, Waksal has held various other board and advisory roles across numerous organizations. His involvement with Acasti Pharma, Senesco Technologies, and Neptune Technologies exemplifies his commitment to advancing scientific research and improving public health through innovation in biotechnology.

Education and Achievements

Dr. Waksal's educational background is rooted in the sciences. He earned his Doctor of Medicine (MD) from the esteemed Tufts University School of Medicine, which equipped him with in-depth knowledge of medical science and a strong foundation in clinical practices. Prior to that, he completed his Bachelor's Degree at Oberlin College, an institution recognized for fostering a liberal arts education that promotes critical thinking and interdisciplinary studies.

His academic achievements have continuously propelled his career, allowing him to bridge the gap between medical research and practical applications in the business realm. As a director and executive in various organizations, he has led teams in the strategic development of breakthrough therapies, significantly impacting patient care.

Achievements

Harlan Waksal's achievements extend well beyond his executive roles. He has been a vital part of numerous boards and committees, lending his insight and strategic thinking to drive the initiatives of various organizations. His tenure as the Chairman of the Board at the American Committee for the Weizmann Institute of Science is a testament to his dedication toward advancing scientific education and research. He has also contributed to the Montclair Art Museum as a Trustee, demonstrating his diverse interests and community involvement.

Moreover, Waksal's experience as a Member of the Technology Advisory Board at the New Jersey Edison Innovation Fund illustrates his ongoing commitment to fostering innovation and supporting emerging technologies within New Jersey and beyond.

Waksal's leadership capabilities have made him a sought-after advisor and an influential figure in the biotechnology field. His visionary approach, combined with his dedication to fostering scientific innovation, underscores his valuable contribution to the industry. Whether through his time spent at Kadmon Holdings or his foundational work at ImClone Systems, Harlan Waksal exemplifies what it means to be a leader at the forefront of medical and technological advancements.